These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 29310122)

  • 41. Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018.
    Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.
    Warny M; Pepin J; Fang A; Killgore G; Thompson A; Brazier J; Frost E; McDonald LC
    Lancet; 2005 Sep 24-30; 366(9491):1079-84. PubMed ID: 16182895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Clostridium difficile spo0A gene is a persistence and transmission factor.
    Deakin LJ; Clare S; Fagan RP; Dawson LF; Pickard DJ; West MR; Wren BW; Fairweather NF; Dougan G; Lawley TD
    Infect Immun; 2012 Aug; 80(8):2704-11. PubMed ID: 22615253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Epidemiology of Clostridium difficile PCR ribotype 027 in the Netherlands 2005-present and the emergence of other subtypes].
    Notermans DW; van der Kooi TI; Goorhuis A; Debast SB; van Benthem BH; Kuijper EJ
    Ned Tijdschr Geneeskd; 2008 Aug; 152(35):1937-40. PubMed ID: 18808085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era.
    Hookman P; Barkin JS
    Dig Dis Sci; 2007 Apr; 52(4):1071-5. PubMed ID: 17380404
    [No Abstract]   [Full Text] [Related]  

  • 46. [Infections caused by Clostridium difficile].
    Rodríguez-Pardo D; Mirelis B; Navarro F
    Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):254-63. PubMed ID: 23411363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genomic and phenotypic diversity of Clostridium difficile during long-term sequential recurrences of infection.
    Sachsenheimer FE; Yang I; Zimmermann O; Wrede C; Müller LV; Gunka K; Groß U; Suerbaum S
    Int J Med Microbiol; 2018 Apr; 308(3):364-377. PubMed ID: 29490877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain.
    Kuehne SA; Collery MM; Kelly ML; Cartman ST; Cockayne A; Minton NP
    J Infect Dis; 2014 Jan; 209(1):83-6. PubMed ID: 23935202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomic investigation of a sequence type 67 Clostridium difficile causing community-acquired fulminant colitis in Hong Kong.
    Cao H; Wong SC; Yam WC; Liu MC; Chow KH; Wu AK; Ho PL
    Int J Med Microbiol; 2019 Jul; 309(5):270-273. PubMed ID: 31113737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two Distinct Patterns of Clostridium difficile Diversity Across Europe Indicating Contrasting Routes of Spread.
    Eyre DW; Davies KA; Davis G; Fawley WN; Dingle KE; De Maio N; Karas A; Crook DW; Peto TEA; Walker AS; Wilcox MH;
    Clin Infect Dis; 2018 Sep; 67(7):1035-1044. PubMed ID: 29659747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil.
    Balassiano IT; dos Santos-Filho J; Vital-Brazil JM; Nouér SA; Souza CR; Brazier JS; Ferreira Ede O; Domingues RM
    Antonie Van Leeuwenhoek; 2011 Feb; 99(2):249-55. PubMed ID: 20623188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Clostridium difficile infection caused by the NAP1/RT027 strain on severity and recurrence during an outbreak and transition to endemicity in a Mexican tertiary care center.
    Tamez-Torres KM; Torres-González P; Leal-Vega F; García-Alderete A; López García NI; Mendoza-Aguilar R; Galindo-Fraga A; Bobadilla-Del Valle M; Ponce de León A; Sifuentes-Osornio J
    Int J Infect Dis; 2017 Dec; 65():44-49. PubMed ID: 28986313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the virulence of three novel clade 2 Clostridioides (Clostridium) difficile strains and a two-year screening in animals and humans in Brazil.
    Diniz AN; Moura LNF; Cruz DSG; Oliveira Junior CA; Figueiredo HCP; Cunha JLR; Vilela EG; Kuijper EJ; Wilcox MH; Lobato FCF; Silva ROS
    PLoS One; 2022; 17(8):e0273013. PubMed ID: 36026500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An epidemic, toxin gene-variant strain of Clostridium difficile.
    McDonald LC; Killgore GE; Thompson A; Owens RC; Kazakova SV; Sambol SP; Johnson S; Gerding DN
    N Engl J Med; 2005 Dec; 353(23):2433-41. PubMed ID: 16322603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clostridium difficile PCR Ribotype 018, a Successful Epidemic Genotype.
    Baldan R; Trovato A; Bianchini V; Biancardi A; Cichero P; Mazzotti M; Nizzero P; Moro M; Ossi C; Scarpellini P; Cirillo DM
    J Clin Microbiol; 2015 Aug; 53(8):2575-80. PubMed ID: 26041894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Degradation-resistant trehalose analogues block utilization of trehalose by hypervirulent Clostridioides difficile.
    Danielson ND; Collins J; Stothard AI; Dong QQ; Kalera K; Woodruff PJ; DeBosch BJ; Britton RA; Swarts BM
    Chem Commun (Camb); 2019 Apr; 55(34):5009-5012. PubMed ID: 30968891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The flagellin FliC of Clostridium difficile is responsible for pleiotropic gene regulation during in vivo infection.
    Barketi-Klai A; Monot M; Hoys S; Lambert-Bordes S; Kuehne SA; Minton N; Collignon A; Dupuy B; Kansau I
    PLoS One; 2014; 9(5):e96876. PubMed ID: 24841151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-toxin
    Anwar F; Roxas BAP; Shehab KW; Ampel NM; Viswanathan VK; Vedantam G
    Emerg Microbes Infect; 2022 Dec; 11(1):1982-1993. PubMed ID: 35880487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.